
Minerva Neurosciences is a biotechnology business based in the US. Minerva Neurosciences shares (NERV) are listed on the NASDAQ and all prices are listed in US Dollars. Minerva Neurosciences employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Minerva Neurosciences stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NERV. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Minerva Neurosciences stock price (NASDAQ: NERV)
Use our graph to track the performance of NERV stocks over time.Minerva Neurosciences shares at a glance
Latest market close | $2.21 |
---|---|
52-week range | $1.26 - $15.27 |
50-day moving average | $2.67 |
200-day moving average | $4.50 |
Wall St. target price | $6.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.19 |
Buy Minerva Neurosciences stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Minerva Neurosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Minerva Neurosciences price performance over time
Historical closes compared with the close of $2.21 from 2023-01-26
1 week (2023-01-20) | 13.33% |
---|---|
1 month (2022-12-27) | -5.96% |
3 months (2022-10-27) | -22.73% |
6 months (2022-07-27) | -12.65% |
1 year (2022-01-26) | 202.24% |
---|---|
2 years (2021-01-27) | -31.37% |
3 years (2020-01-27) | 8.18 |
5 years (2018-01-26) | 6.6 |
Minerva Neurosciences financials
Gross profit TTM | $-16,838,947 |
---|---|
Return on assets TTM | -20.93% |
Return on equity TTM | -675.09% |
Profit margin | 0% |
Book value | $-2.67 |
Market capitalisation | $11.7 million |
TTM: trailing 12 months
Minerva Neurosciences share dividends
We're not expecting Minerva Neurosciences to pay a dividend over the next 12 months.
Have Minerva Neurosciences's shares ever split?
Minerva Neurosciences's shares were split on a 1:8 basis on 20 June 2022. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Minerva Neurosciences shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Minerva Neurosciences shares which in turn could have impacted Minerva Neurosciences's share price.
Minerva Neurosciences share price volatility
Over the last 12 months, Minerva Neurosciences's shares have ranged in value from as little as $1.26 up to $15.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Minerva Neurosciences's is -0.0687. This would suggest that Minerva Neurosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Minerva Neurosciences has bucked the trend.
Minerva Neurosciences overview
Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc.
Minerva Neurosciences in the news
Minerva (NERV) Down; FDA Denies Review Schizophrenia Drug NDA
The Petri Dish: Group eyes Biogen Alzheimer's drug price, FDA rejects psych drug application
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
Frequently asked questions
What percentage of Minerva Neurosciences is owned by insiders or institutions?Currently 3.425% of Minerva Neurosciences shares are held by insiders and 38.557% by institutions. How many people work for Minerva Neurosciences?
Latest data suggests 9 work at Minerva Neurosciences. When does the fiscal year end for Minerva Neurosciences?
Minerva Neurosciences's fiscal year ends in December. Where is Minerva Neurosciences based?
Minerva Neurosciences's address is: 1601 Trapelo Road, Waltham, MA, United States, 02451 What is Minerva Neurosciences's ISIN number?
Minerva Neurosciences's international securities identification number is: US6033802058 What is Minerva Neurosciences's CUSIP number?
Minerva Neurosciences's Committee on Uniform Securities Identification Procedures number is: 603380106
More guides on Finder
-
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert